Molecular Mechanism of Reversal Effect of Monoclonal Antibody to Basic Fibroblast Growth Factor-Mediated Expression of P-glycoprotein on Multiple Drug Resistance in Adriamycin-Resistant Human Breast Cancer Cell Line MCF-7/ADM

CHEN Wen-hui,XU Meng,DU Chao-chao,ZHAO Jian-fu,PAN Lan-hong,LI Han-chu,XIANG Jun-jian,DENG Ning
DOI: https://doi.org/10.3781/j.issn.1000-7431.2013.01.002
2013-01-01
Tumor
Abstract:Objective: To investigate the mechanism of reversal effect of bFGF mAb (monoclonal antibody to basic fibroblast growth factor)-mediated expression of P-gp (permeability glycoprotein) on MDR (multidrug resistance) in ADM (adriamycin)-resistant human breast cancer cell line MCF-7/ADM. Methods: The effects of bFGF mAb on the proliferation of MCF-7/ADM cells and the reversal of MDR were detected by CCK-8 (cell counting kit-8) method. The cell cycle distribution of MCF-7/ADM cells and the expression of P-gp and intracellular fluorescence intensity of Rho123 (rhodamine 123) in MCF-7/ADM cells after bFGF mAb intervention were analyzed by flow cytometry. The expressions of MDR 1 (multidrug resistance protein 1) and bFGF mRNAs in MCF-7/ADM cells were examined by real-time fluorescence quantitative PCR. Results: The growth inhibition rates of MCF-7 cells and MCF-7/ADM cells after treatment with 1 μg/mL bFGF mAb were (19.87±1.05)% and (27.34±2.79)% (P < 0.01). bFGF mAb intervention could reverse ADM-, GEM (gemcitabine)- and OXA (oxaliplatin)-resistance of MCF-7/ADM cells, and the corresponding reversal index were 4.46, 4.25 and 2.18, respectively. As compared with the MCF-7/ADM cells without bFGF mAb intervention, the cell cycle of MCF-7/ADM cells after bFGF mAb intervention was arrested at G0/G1 phase, the expression level of P-gp was down-regulated, the intracellular Rho123 fluorescence intensity was increased, and the expression levels of MDR 1 and bFGF mRNAs were both decreased (P < 0.01). Conclusion: bFGF mAb can inhibit the proliferation of MCF-7/ADM and reverse MDR. This mechanism may be related to down-regulation of the expression levels of MDR 1 and P-gp, inhibition of the function of P-gp, and increasement of intracellular concentration of chemotherapeutic drugs. DOI:10.3781/j.issn.1000-7431.2013.01.002
What problem does this paper attempt to address?